Clinical Practice Guidelines for the Management of Blastomycosis: 2008 Update by the Infectious Diseases Society of America

TLDR

These evidence‑based guidelines, developed by an IDSA expert panel, update the 2000 recommendations and reflect newer antifungal options and increased incidence in immunosuppressed patients. They are designed for clinicians treating patients with blastomycosis. The update incorporates literature from 2000–2006 and includes specific recommendations for pediatric treatment.

Abstract

Evidence-based guidelines for the management of patients with blastomycosis were prepared by an Expert Panel of the Infectious Diseases Society of America. These updated guidelines replace the previous management guidelines published in the April 2000 issue of Clinical Infectious Diseases. The guidelines are intended for use by health care providers who care for patients who have blastomycosis. Since 2000, several new antifungal agents have become available, and blastomycosis has been noted more frequently among immunosuppressed patients. New information, based on publications between 2000 and 2006, is incorporated in this guideline document, and recommendations for treating children with blastomycosis have been noted.